Varun Reddy Dasari

Varun Reddy Dasari

Active Director Whole-Time Director DIN 07031141
DIN 07031141 First appointment Dec 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since Dec 2014
Shareholding value •••• Premium profile

About Varun Reddy Dasari

Data last updated:

Varun Reddy Dasari is a Whole-Time Director at Sri Rama Pharmaceutical Distributors Private Limited (since 2021), Managing Director at Dedeepya Pharma Private Limited (since 2014) and Director at Vm Infini Private Limited (since 2021), and holds 4 more current directorships. The companies operate in Pharma, Information Technology and Real Estate. The 4 current companies with reported revenue have a combined latest revenue of ₹431 Cr; the largest is Sri Rama Pharmaceutical Distributors Private Limited at ₹263 Cr (FY 2025).

DIN 07031141
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 11 Dec 2014
Oldest Company Age 11 yrs
Largest company Sri Rama Pharmaceutical Distributors Private Limited · ₹263 Cr (FY 2025)
Combined revenue ₹431 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director10 Nov 20212021₹263 Cr (FY 2025)Active
Dedeepya Pharma Private Limited U24100TG2014PTC096778
Managing Director11 Dec 20142014₹167 Cr (FY 2024)Active
Vm Infini Private Limited U45201TG2021PTC152920
Director07 Jul 20212021₹2 Lakh (FY 2024)Active
Sri Rama Avenues Private Limited U43299TS2023PTC171419
Director28 Mar 20232023₹76,166 (FY 2025)Active
Director03 Jun 20252025Active
Sri Nivi Avenues Private Limited U68100TS2024PTC187205
Director03 Jul 20242024Active
Designated Partner21 Feb 20172017Active

Directorship timeline

Open interactive timeline →
Dedeepya Pharma Private Limited
Vm Infini Private Limited
Sri Rama Avenues Private Limited
Sterling Heights Llp
Premium access

Shareholding and investment profile for Varun Reddy Dasari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Varun Reddy Dasari

Varun Reddy Dasari currently holds 7 directorships: Sri Rama Pharmaceutical Distributors Private Limited (Whole-Time Director, since 10 Nov 2021, revenue ₹263 Cr (FY 2025)); Dedeepya Pharma Private Limited (Managing Director, since 11 Dec 2014, revenue ₹167 Cr (FY 2024)); Vm Infini Private Limited (Director, since 07 Jul 2021, revenue ₹2 Lakh (FY 2024)); Sri Rama Avenues Private Limited (Director, since 28 Mar 2023, revenue ₹76,166 (FY 2025)); Sterling Heights Avenues Private Limited (Director, since 03 Jun 2025); and 2 more.

Varun Reddy Dasari was first appointed on 11 Dec 2014 as Managing Director at Dedeepya Pharma Private Limited. The most recent appointment on record is 03 Jun 2025 at Sterling Heights Avenues Private Limited.

The 4 current companies of Varun Reddy Dasari that report revenue have a combined latest revenue of ₹431 Cr: Sri Rama Pharmaceutical Distributors Private Limited ₹263 Cr (FY 2025); Dedeepya Pharma Private Limited ₹167 Cr (FY 2024); Vm Infini Private Limited ₹2 Lakh (FY 2024); Sri Rama Avenues Private Limited ₹76,166 (FY 2025).

The current boards of Varun Reddy Dasari's companies include Mahidhar Dasari Reddy (Sri Rama Pharmaceutical Distributors Private Limited), Sambit Mohanty (Sri Rama Pharmaceutical Distributors Private Limited), Venkata Sarva Sai Subramanyam Bachotti (Sri Rama Pharmaceutical Distributors Private Limited), Manjula Dasari (Dedeepya Pharma Private Limited), Niharika Reddy Kondakindi (Dedeepya Pharma Private Limited), Preeti Reddy Dasari (Dedeepya Pharma Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available